Expansion of CD4+CD45RO+CD25- T cells in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden [2]

AIDS

Volumn 18, Issue 11, 2004, Pages 1609-1610

  Carbone, Javier ^a   Gil, Juana ^a   Rodríguez Sainz, Carmen ^a   Fernández Cruz, Eduardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD45RO ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; T LYMPHOCYTE; TREATMENT FAILURE; VIREMIA; VIRUS LOAD;

ANTIGENS, CD4; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HEROIN DEPENDENCE; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, INTERLEUKIN-2; VIRAL LOAD;

EID: 3843076335     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000131368.13447.c1     Document Type: Letter

References (8)

1. Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 2003, 77:10900-10909.
2. David D, Keller H, Nait-Ighil L, Treilhou MP, Joussemet M, Dupont B, et al. Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy. AIDS 2002, 16:1093-1101.
3. Levy Y, Durier C, Krzysiek R, Rabian C, Capitant C, Lascaux AS, et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial. AIDS 2003, 17: 343-351.
4. Carbone J, Gil J, Benito JM, Navarro J, Munoz-Fernandez A, Bartolome J, et al. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users. AIDS 2000, 14:2823-2829.
5. Carbone J, Gil J, Benito JM, Muñoz-Fernandez MA, Fernández-Cruz E. Elevated levels of CD4+CD7- T cells in HIV infection add to the prognostic value of low CD4+ T cell levels and HIV-1-RNA quantification. AIDS 2001, 15:2459-2560.
6. Wrightham M, Schimpf A, Pennington H, Walker F, Sewell H. HIV induces modulation of functionally important cellular antigens. Clin Exp Immunol 1991, 85:75-79.
7. Hofmann B, Nishanian P, Fahey JL, Esmail I, Jackson AL, Detels R, et al. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin Immunol Immunopathol 1991, 61:212-224.
8. Janossy G, Borthwick N, Lomnitzer R, Medina E, Squire SB, Phillips AN, et al. Lymphocyte activation in HIV infection. I. Predominant proliferative defects among CD45RO+ cells of the CD4 and CD8 lineages. AIDS 1993, 7:613-62.